×
News Home

Does Jazz Pharmaceuticals PLC (JAZZ) Have What it Takes to be in Your Portfolio Monday?

Monday, May 16, 2022 01:42 PM | InvestorsObserver Analysts
Does Jazz Pharmaceuticals PLC (JAZZ) Have What it Takes to be in Your Portfolio Monday?

The 73 rating InvestorsObserver gives to Jazz Pharmaceuticals PLC (JAZZ) stock puts it near the top of the Biotechnology industry. In addition to scoring higher than 96 percent of stocks in the Biotechnology industry, JAZZ’s 73 overall rating means the stock scores better than 73 percent of all stocks.

Overall Score - 73
JAZZ has an Overall Score of 73. Find out what this means to you and get the rest of the rankings on JAZZ!

What do These Ratings Mean?

Searching for the best stocks to invest in can be difficult. There are thousands of options and it can be confusing on what actually constitutes a great value. InvestorsObserver allows you to choose from eight unique metrics to view the top industries and the best performing stocks in that industry. A score of 73 would rank higher than 73 percent of all stocks.
Our proprietary scoring system captures technical factors, fundamental analysis and the opinions of analysts on Wall Street. This makes InvestorsObserver’s overall rating a great way to get started, regardless of your investing style. Percentile-ranked scores are also easy to understand. A score of 100 is the top and a 0 is the bottom. There’s no need to try to remember what is “good” for a bunch of complicated ratios, just pay attention to which numbers are the highest.

What's Happening With Jazz Pharmaceuticals PLC Stock Today?

Jazz Pharmaceuticals PLC (JAZZ) stock is trading at $148.23 as of 1:25 PM on Monday, May 16, a gain of $1.74, or 1.19% from the previous closing price of $146.49. The stock has traded between $146.37 and $149.17 so far today. Volume today is light. So far 159,480 shares have traded compared to average volume of 588,423 shares. Click Here to get the full Stock Report for Jazz Pharmaceuticals PLC stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App